1. Home
  2. BLUE vs CHSCP Comparison

BLUE vs CHSCP Comparison

Compare BLUE & CHSCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLUE
  • CHSCP
  • Stock Information
  • Founded
  • BLUE 1992
  • CHSCP N/A
  • Country
  • BLUE United States
  • CHSCP United States
  • Employees
  • BLUE N/A
  • CHSCP N/A
  • Industry
  • BLUE Biotechnology: Biological Products (No Diagnostic Substances)
  • CHSCP Farming/Seeds/Milling
  • Sector
  • BLUE Health Care
  • CHSCP Industrials
  • Exchange
  • BLUE Nasdaq
  • CHSCP Nasdaq
  • Market Cap
  • BLUE 82.2M
  • CHSCP N/A
  • IPO Year
  • BLUE 2013
  • CHSCP N/A
  • Fundamental
  • Price
  • BLUE $8.01
  • CHSCP $28.43
  • Analyst Decision
  • BLUE Hold
  • CHSCP
  • Analyst Count
  • BLUE 9
  • CHSCP 0
  • Target Price
  • BLUE $49.14
  • CHSCP N/A
  • AVG Volume (30 Days)
  • BLUE 446.9K
  • CHSCP N/A
  • Earning Date
  • BLUE 11-14-2024
  • CHSCP N/A
  • Dividend Yield
  • BLUE N/A
  • CHSCP N/A
  • EPS Growth
  • BLUE N/A
  • CHSCP N/A
  • EPS
  • BLUE N/A
  • CHSCP N/A
  • Revenue
  • BLUE $53,120,000.00
  • CHSCP N/A
  • Revenue This Year
  • BLUE $145.88
  • CHSCP N/A
  • Revenue Next Year
  • BLUE $239.89
  • CHSCP N/A
  • P/E Ratio
  • BLUE N/A
  • CHSCP N/A
  • Revenue Growth
  • BLUE 144.50
  • CHSCP N/A
  • 52 Week Low
  • BLUE $5.80
  • CHSCP N/A
  • 52 Week High
  • BLUE $38.40
  • CHSCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • BLUE 47.10
  • CHSCP 50.12
  • Support Level
  • BLUE $8.03
  • CHSCP $28.10
  • Resistance Level
  • BLUE $10.28
  • CHSCP $28.52
  • Average True Range (ATR)
  • BLUE 0.80
  • CHSCP 0.39
  • MACD
  • BLUE -0.04
  • CHSCP 0.09
  • Stochastic Oscillator
  • BLUE 16.24
  • CHSCP 84.05

About BLUE bluebird bio Inc.

bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.

About CHSCP CHS Inc. 8% Cumulative Redeemable Preferred Stock

CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).

Share on Social Networks: